Showing results (331-340 of 1,607) with videos related to

Sort By:
Pageof 161
JAMA Oncology|August 4, 2022
Association Between Prostate-Specific Antigen Screening and Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White US VeteransMichael V Sherer, Edmund M Qiao, Nikhil V Kotha, et al.
JAMA Oncology|August 11, 2022
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19Sabine Haggenburg, Quincy Hofsink, Birgit I Lissenberg-Witte, et al.
JAMA Oncology|May 22, 2020
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical TrialDavid A Reardon, Alba A Brandes, Antonio Omuro, et al.
JAMA Oncology|May 6, 2021
Hyperthermic Intraperitoneal Chemotherapy for Ovarian and Colorectal Cancer: A ReviewRuby M van Stein, Arend G J Aalbers, Gabe S Sonke, et al.
JAMA Oncology|February 2, 2023
Cardiovascular Magnetic Resonance Imaging in Patients With Ibrutinib-Associated CardiotoxicityBenjamin Buck, Aaron P Chum, Mitkumar Patel, et al.
JAMA Oncology|August 19, 2021
Effects of Exercise on Cardiorespiratory Fitness and Biochemical Progression in Men With Localized Prostate Cancer Under Active Surveillance: The ERASE Randomized Clinical TrialDong-Woo Kang, Adrian S Fairey, Normand G Boulé, et al.
JAMA Oncology|August 18, 2022
Patterns of Practice and Improvements in Survival Among Patients With Stage 2/3 Rectal Cancer Treated With Trimodality TherapyHagen F Kennecke, Henry T Bahnson, Bruce Lin, et al.
JAMA Oncology|August 18, 2022
Activity of Cabazitaxel in Metastatic or Inoperable Locally Advanced Dedifferentiated Liposarcoma: A Phase 2 Study of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG)Roberta Sanfilippo, Richard L Hayward, Jammbe Musoro, et al.
JAMA Oncology|August 21, 2025
GLP-1 Receptor Agonists and Cancer Risk in Adults With ObesityHao Dai, Yongqiu Li, Yao An Lee, et al.
JAMA Oncology|December 11, 2025
Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis of the RxPONDER Randomized Clinical TrialIrene M Kang, Jamie K Forschmiedt, Michelle M Loch, et al.
Pageof 161